larotrectinib 25 MG Oral Capsule [Vitrakvi]
RxNorm concept 2105657, branded drug (sbd). Prescribable name: VITRAKVI 25 MG Oral Capsule.
- RxCUI
- 2105657
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2105657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vitrakvi 25 MG (as 30.7 MG larotrectinib sulfate) Oral Capsule; Vitrakvi 25 MG Oral Capsule
Related concepts
- larotrectinib 25 MG (SCDC, consists of)
- larotrectinib 25 MG [Vitrakvi] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Vitrakvi (BN, has ingredient)
- larotrectinib 25 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2105657 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2105657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2105657. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.